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Abstract.  The removal of introns from eukaryotic pre- 
mRNA occurs in a large ribonucleoprotein complex 
called the spliceosome. We have generated a monoclo- 
nal antibody (rnAb  16H3) against four of the family of 
six SR proteins,  known regulators of splice site selec- 
tion and spliceosome assembly. In addition to the 
reactive SR proteins,  SRp20, SRp40, SRp55, and 
SRp75,  mAb  16H3 also binds ",,20 distinct nuclear 
proteins in human,  frog, and Drosophila extracts, 
whereas yeast do not detectably express the epitope. 
The antigens are shown to be nuclear,  normucleolar, 
and concentrated at active sites of RNA polymerase II 
transcription  which suggests their involvement in pre- 
mRNA processing.  Indeed, most of the reactive pro- 
teins observed in nuclear extract are detected in 
spliceosomes (E and/or B complex) assembled in 
vitro, including the U1 70K component of the U1 
small nuclear ribonucleoprotein particle and both 
subunits of U2AE Interestingly,  the 16H3 epitope was 
mapped to a 40-amino acid polypeptide composed al- 
most exclusively of arginine alternating  with glutamate 
and aspartate.  All of the identified antigens,  including 
the human homolog of yeast Prp22 (HRH1), contain a 
similar structural element characterized by arginine al- 
ternating  with serine,  glutamate,  and/0r aspartate. 
These results indicate that many more spliceosomal 
components contain such arginine-rich  domains.  Be- 
cause it is conserved among metazoans,  we propose 
that the ~alternating  arginine" domain recognized by 
mAb  16H3 may represent a common functional ele- 
ment of pre-mRNA splicing factors. 
p 
R~CURSOR-mRNA  splicing takes place in a large ribo- 
nucleoprotein  (RNP)  m  complex designated  the spli- 
ceosome (Guthrie,  1991; Moore et al.,  1993).  This 
complex of RNA and protein is assembled at intron/exon 
boundaries in the pre-mRNA such that two exons are brought 
together and, subsequently, the intron is removed by two se- 
quential  transesterification  reactions.  Because spliceosome 
assembly is  the  ultimate  determinant  of exon  definition, 
splice site selection,  and the fidelity of splicing,  efforts to 
characterize  the RNA and protein components of  the spliceo- 
some are ongoing. Small nuclear ribonucleoprotein particles 
(snRNPs) have been described biochemically as complexes 
containing  specific sets of proteins associated with U1, U2, 
and U4/U5/U6 snRNAs, and these are known  to interact 
with the pre-mRNA during spliceosome assembly (reviewed 
in Moore et al.,  1993).  In addition,  a growing  number of 
non-snRNP proteins have been described by genetic or bio- 
chemical means, bringing  the number of proteins in active 
mammalian  spliceosomes to •50  (Gozani  et al.,  1994). 
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Genetic dissection of the splicing reaction in the yeast Sac- 
charomyces cerevisiae has  yielded functional  information 
about  27  genes  essential  for  pre-mRNA  processing  (cf. 
Moore et al., 1993; Guthrie,  1991). A number of these PRP 
gene products appear to be either  snRNP components or 
snRNP-associated  factors.  The sequences of many provide 
clues to how they function  in the spliceosome:  some have 
RNA recognition  motifs (RRMs) or zinc-finger motifs, and 
a number have homology with ATPases or RNA helicases 
(Kenan et al., 1991; Guthrie,  1991; Moore et al., 1993). Re- 
cently, a number of mammalian homologs of PRP genes have 
been cloned, and relationships have been drawn between fac- 
tors identified in human cells biochemically and in yeast ge- 
netically. For example,  three protein components of human 
SF3a, an activity required for the assembly of the mature 17S 
U2 snRNP at the branchpoint,  have been shown to be the 
functional homologues of the yeast genes PRP9, PRPll, and 
PRP21 (Bennett and Reed, 1993; Brosi et al., 1993; Legrain 
and Chapon,  1993; Chiara et al., 1994). While many of the 
yeast PRP gene homologues have not yet been identified in 
metazoans,  it appears  that the functions  carried out by the 
yeast proteins are also required in pre-mRNA splicing  by 
higher  eukaryotes. 
It is highly likely that additional regulators of pre-mRNA 
splicing are expressed in metazoans  where splice site selec- 
tion is often modulated.  In particular,  a family of non-snRNP 
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sential for splicing in vitro but have not been found in yeast 
(Zahler et al., 1992). Although SR proteins interact with the 
U1 snRNP and are required for recruitment of the U1 snRNP 
to the 5' splice site (Eperon et al., 1993; Khotz et al., 1994; 
Staknis  and Reed,  1994),  none have been detected  in the 
highly purified spliceosome assembled in vitro (Bennett et 
al., 1992a). Thus, essential splicing factors do exist that have 
not been approachable  genetically  in yeast or through the 
biochemistry of the spliceosome. The discovery  of SR pro- 
teins was facilitated by an immunological tool, the mAb 104 
(Roth et al., 1989). This study identifies a new mAb (16H3) 
with specificity  for four (SRp20,  SRp40, SRp55, SRp75) of 
the family  of six SR proteins.  The epitope recognized by 
mAb 16H3 is expressed by at least 20 distinct nuclear pro- 
teins and appears to be conserved among metazoan splicing 
factors, such as HRH1, U2AF, and U1 70K proteins. In addi- 
tion,  mAb  16H3  detects  many components of the earliest 
spliceosomal complex, E, and of the mature complex B. 
Materials and Methods 
Proteins and Antibodies 
SR proteins were purified from calf thymus or Hela cells as described in 
Zahler et al. (1992).  The GEX-2T vector (Smith and Johnson, 1988) was 
used to generate a protein fusion between glutathione S-transferase (GST) 
and the open reading frame of Drosophila SRp55 (Roth et al., 1991). The 
bacterially expressed fusion protein was purified by chromatography on 
glutathione  agarose  (Smith  and  Johnson,  1988).  U2AF65-GST  and 
U2AF35-GST  vectors were kindly provided by M. Green (University of 
Mass. Worcester, MA.) and J. Wu (Harvard University, Cambridge, MA), 
respectively. A  fusion construct encoding maltose binding protein and 
amino acids 151-346  of HRH1  was generously provided by M. Ohno and 
Y. Shimura (Kyoto University, Kyoto, Japan). Bacterially expressed hetero- 
geneous nuclear ribonucleoprotein (hnRNP) U and mAbs 4F4 (anti-hnRNP 
C), 4B10 (anti-hnRNP A), and 306 (anti-hnRNP U) were generous gifts 
of G. Dreyfuss (University of Pennsylvania, Philadelphia, PA).  Y12 mAb 
supernatant was the generous gift of Joan Steitz (Yale University, New Ha- 
ven, CT). Nuclear and S100 extracts were prepared from HeLa cells and 
Kc cells as described in Dignam et al. (1983). Extracts of whole HeLa cells, 
S. cerevisiae,  and Schizosaccharomyces  pombe were prepared by sonication 
in NEST-2  buffer as described in Zahler et al. (1993a).  E  and B splice- 
osomal complexes were the generous gifts of R. Reed (Harvard University); 
they were assembled on biotinylated AdML pre-mRNA and affinity purified 
according to Bennett et al. (1992a). 
Generation of mAbs 
Mice beating the Robertsonian translocation (RBF/DnJ; Jackson Labora- 
tory, Bar Harbor, ME) were immunized initially with purified dephosphor- 
ylated bovine SRp55 and subsequently with dSRp55-GST. Immunogen was 
emulsified with complete and subsequently with incomplete Freund's adju- 
vant (Cappell Laboratories, Cockranville, PA).  Mice were boosted every 
2 wk for 3 too, and test bleeds were taken. One test bleed showed a positive 
reaction with calf thymus SR proteins on an immunoblot. The spleen cells 
of  the positive mouse were fused with Fox-NY bybridoma cells, and hybrids 
were selected as described by "Ihggart and Samloff (1983).  After 10 d, hy- 
bridoma supernatants were tested for reactivity with SR proteins (see above) 
by ELISA (Harlow and Lane,  1988).  Positive clones were subcloned by 
serial dilution and tested by immunoblot for their specificity for SR pro- 
teins. 
Immunostaining 
L cells grown on acid-washed coverslips were fixed with acetone at -20°C 
for 2 rain, rinsed twice with PBS containing 10 mM MgC12, and exposed 
to hybridoma supernatant at room temporamre for 1 h. After three washes 
in PBS, coverslips were incubated for 1 h with RITC-conjugated goat an- 
ti-mouse IgG (Jackson Immunoreseareh Laboratories, Inc., West Grove, 
PA). Washed coverslips were then mounted in 50% glycerol containing 0.5 
/tg/ml DAPI. FOr Drosophila melanogaster  polytene chromosome spreads, 
salivary glands from third instar larvae were prepared by Dr. B. Ostrow ac- 
cording to the method of Silver et al. (1978). 
lmmunoblotting and lmmunoprecipitation 
For immunoblotting, SDS-polyacrylamide gels were transferred to nitro- 
cellulose, stained with Fonceau S, blocked for 10 rain at room temperature 
in 3%BSA in TBST (50 raM Tris-HCl, pH 8.0, 150 mM NaCI, 0.05% 
Tween 20), and incubated for 1 h at room temperature in primary antibody. 
Blots were then washed three times in TBST and processed for colorimetric 
or ECL (Amersham Corp., Arlington Heights, IL) detection using the Vec- 
tastain ABC kit (Vector Laboratories, Inc., Burlingame, CA). mAb 16H3 
was used as undiluted hybridoma supernatant. 3G6 (anti-hnRNP U-) ascites 
fluid was diluted 1:1,000 in 20%  FCS 0Biowhittaker,  Inc., Walkersville, 
MD). 
Heterogeneous  nuclear  ribonucleoprotein  (hnRNP)  complexes  and 
snRNPs were immunoprecipitated from an extract of unlabeled HeLa cells 
as follows: 109 HeLa cells were harvested from a suspension culture ex- 
tracted in 12 ml NET-2 buffer (50 mM Tris-HC1,  pH 7.4;  150 mM NaCI; 
0.05% NP-40) plus 1 mM aprotinin and 1 mM PMSF and sonicated on ice 
for three 30-s bursts. The extract was centrifuged for 15 min at 4°C at 17,000 
g. The supernatant was adjusted to 15 ml with NET-2, and 5 ml each was 
added to  100/A Gammabind (Pharmacia Inc., Piscataway,  NJ) or 10 pl 
magnetic beads (Dynal Inc., Great Neck, NY) previously coated with either 
10/tl 4F4 (anti-hnRNP C) ascites fluid in 20% FCS, 1 ml Yl2-conditioned 
medium (anti-Sin), 0.5 ml anti-Ul 70K mAb (Billintr~ et al., 1982), or 20% 
FCS alone. Beads and extracts were incubated together at 4°C on a rotator 
for 2 h. The beads were then washed with 5  x  10 ml ice-cold NET-2 over 
the course of 1 h. The final bead pellet was extracted in protein sample 
buffer and subjected to SDS-PAGE, after which the gel was transferred to 
nitrocellulose and cut into strips. For immunoblot detection, Y12 was used 
as undiluted hybridoma supernatant. 4F4 and 41310 (anti-hnRNP A1) ascites 
fluid were diluted 1:1,000 in 3% BSA in TBST. 
For immunoprecipitation of 32p-labeled RNA, 5  x  l0  T HeLa cells were 
grown in suspension for 4 h in phosphate-free medium plus 5 mCi ortho- 
[32p]phosphate.  Cells were harvested by centrifugation at 1,000 g, washed 
once in PBS, and extracted in NET-2 as described above. Immune com- 
plexes were extracted from the beads with protein sample buffer for protein 
or with phenol/chloroform for RNA.  After ethanol precipitation, RNA 
samples were raised in formamide dyes, loaded onto a 5% acrylamide/7 M 
urea gel, and run at  1,700 V/45 W  for 2 h. 
In Vitro  Splicing Reactions 
Capped, 32p-labeled SP64H/~A6  RNA containing two exons and a single 
intron (Ruskin et al.,  1984)  was prepared and used to assay pre-mRNA 
splicing in vitro as described (Znhler et al., 1992).  For antibody inhibition 
studies, IgGs were purified by affinity chromatography on Gammabind, dia- 
lyzed against PBS, diluted to 250/tg/ml, and added to each splicing reaction 
while still on ice and immediately before the addition of  the RNA substrate. 
After incubation at 30°C for 2 h, each reaction was subjected to Proteinase 
K digestion and phenol/chloroform  extraction. RNAs present in the aqueous 
phase were precipited with ethanol, using 2 ~tg tRNA as a carrier. Recov- 
ered RNAs were subjected to denaturing electrophoresis  on 5 % acrylamide 
gels for 3 h at 45 W. 
Expression Screening and Epitope Mapping 
Approximately  1.5  x  105  plaques from a  Lambda Zap Xenopus laevis 
young ovary polyA  + eDNA expression library  (Stratagene Inc.,  Budin- 
game, CA) were screened with mAb 16H3. Reactive plaques were detected 
using the Vectastain ABC kit as described above for immunobiotting. Two 
independent cDNAs were sequenced using the Sequenase system (USB). 
3  x  105 plaques from a genomic S. cerevisiae  library were screened with 
16H3  using the same methods, and no positives were obtained. 
Results 
We generated a monoclonal antibody that recognizes a sub- 
set of the SR protein family of splicing factors. One mouse 
was immunized with a bacterially expressed fusion between 
GST and Drosophila SRp55. Supernatants from 400 clones 
resulting  from  the  spleen  cell  fusion  were  screened  by 
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16H3 was among these positive supernatants and was subse- 
quently characterized by immunoblotting.  Fig.  1 A shows 
that  while  mAb  104  (lane  1)  binds  all  six  SR  proteins 
purified from human HeLa cells, mAb  16H3 (lane 2) only 
binds SRp75, SRp55, SRp40, and SRp20, but not SRp30a or 
b  (ASF/SF2 or SC-35).  mAb  16H3 bound neither SRp30 
band when they were separated from one another on a 13.3 % 
polyacrylamide gel (data not shown). 
Nuclear extract prepared from HeLa cells contains all of 
the factors required for pre-mRNA splicing in vitro, includ- 
ing all of the SR proteins (Krainer and Maniatis, 1985; Zah- 
ler  et  al.,  1993b).  Surprisingly,  nuclear  extract contains 
many more antigens recognized by mAb 16H3 than by mAb 
104, even though mAb 16H3 binds fewer SR proteins. The 
SR proteins as well as two additional, higher molecular mass 
(190 and 125 kD) bands were bound specifically by mAb 104 
(lane 3), but 15-20 16H3 antigens appear in lane 4. Interest- 
ingly, bands comigrating with SRp75,  SRp55, and the two 
high molecular weight bands bound by mAb 104 were read- 
ily detected by mAb 16H3.  16H3-reactive bands comigrating 
with SRp40 and SRp20 were faintly detectable. In contrast 
to nuclear extract, cytoplasmic S100 extract is only compe- 
tent for in vitro splicing upon the addition of one or more 
SR  proteins  (Krainer and  Maniatis,  1985;  Zahler et  al., 
1992).  Thus, the observation that  16H3 antigens (lane 6), 
like SR proteins (lane 5; Zahler et al., 1993b), are much less 
abundant in S100 suggests that at least some of the 16H3 anti- 
gens may have an essential function in pre-mRNA splicing. 
Indeed, the level of only one (145 kD) of the 16H3 antigens 
in S100 is comparable with that detected in nuclear extract 
(compare lanes 4 and 6). 
The mAb 16H3 epitope appears to be conserved through- 
out the animal kingdom but is not detectably expressed by 
yeast cells.  Fig.  1 B  shows  a  mAb  16H3  immunoblot of 
whole HeLa cell extract as well as HeLa nuclear extract, 
Drosophila Kc cell nuclear extract, and Xenopus laevis oo- 
cyte nuclei in which a complex set of reactive polypeptides 
was  observed.  The pattern  of 16H3  antigens  detected in 
whole HeLa cell extract (lane 1) appeared nearly identical 
to that found in nuclear extract (lane 2), suggesting that most 
of the antigens are nuclear. The relative mobilities of some 
of the bands detected in Xenopus  and Drosophila  differed 
from the human antigens, but the overall number of antigens 
was quite similar (lanes 3  and 4). In contrast, no reactive 
polypeptides could be detected in extracts of S. cerevisiae or 
S. pombe (lanes 5 and 6). Moreover, although the 16H3 epi- 
tope is known to be expressed by bacterial cells and to be 
useful in expression screening (see below), we were unable 
to obtain positive plaques in an expression screen of 3  x 
10  ~ pfu from an S.  cerevisiae genomic library. We therefore 
consider the possibility that 16H3 binds an epitope common 
to a  subset  of SR proteins  and  other nuclear proteins in 
metazoan but not yeast cells. 
Immunostaining experiments revealed that 16H3 antigens 
are indeed predominantly nuclear and are localized to active 
sites of polymerase II transcription, mAb 161-13 stained the 
nuclei of  cultured mouse L cells very intensely relative to the 
cytoplasm, while staining of nucleoli was undetectable (Fig. 
2). Denser regions of mAb  16H3 staining appear indistin- 
guishable from staining produced by antibodies against the 
SR protein family, such as mAb 104 (Roth et al., 1989; data 
not  shown),  but  an  even,  grainy  staining  also  extended 
throughout  the  nucleoplasm.  On  polytene  chromosomes 
from the  salivary  gland  of D.  melanogaster,  mAb  16H3 
reacted with discreet bands of chromatin and, in particular, 
with developmental chromosome puffs (Fig. 3). RNA poly- 
merase II,  Sm antigens,  and 121 and  I22 snRNPs are also 
localized to chromosomal puffs, the sites of high levels of 
gene transcription (Sass,  1982; Sass and Pederson,  1984). 
Transcription also occurs in bands that are not puffed, and 
therefore the banded staining seen with mAb 16H3 is not in- 
Figure  /.  mAb  16H3 recognizes  purified 
SRp75,  SRp55, SRIMO, SRp20, and  '~20 
prominent nuclear antigens in extracts from 
human,  frog,  and  fly. (,4) mAb  16H3 and 
mAb 104 immunoblots of SR proteins puri- 
fied from HeLa cells (~0.1 tzg in lanes I and 
2), HeLa cell nuclear extract (10/zg in lanes 
3 and 4) and S100 (10/~g in lanes 5 and 6): 
SRp75,  SRp55,  SRIM0,  SRp30a/b,  and 
SRp20 are indicated by tic marks at the left 
of  lanes I and 3. Lane I was probed with mAb 
104, which reacts with all of the SR proteins. 
Lane 2 was probed with mAb  16H3, which 
binds SRp75, SRp55, SR1M0, and SRp20, but 
not SRp30a/b. mAb 104 binds all of the ca- 
nonical SR proteins in addition to two higher 
molecular  mass bands (asterisks,  190  and 
125 kD) in nuclear extract (lane 3), whereas mAb 16H3 binds many more polypeptides (lane 4). mAb 104 antigens are depleted in S100 
extract 0ane 5), as are mAb 16H3 antigens (lane 6), with the exception of bands at 145, 125, 68, 60, and 45 kD. (B) 200/zg each of 
whole-cell extracts of HeLa cells (lane 1), S.  cerevisiae (lane 6) and S. pombe (lane 5),  10 #g each of HeLa call and Drosophila Kc 
cell nuclear extracts (ICE; lanes 2 and 4), and hand-dissected X. /aev/s  oocyte nuclei (GI~ lane 3) were probed with mAb 16H3. Ponceau 
S staining of the nitrocellulose filter indicated numerous protein bands in the lanes containing the yeast extracts. The faint, low molecular 
mass bands in each of the yeast lanes were also present in blots that were processed in the absence of primary antibody and are, therefore, 
nonspecific. All of the samples in A and B were separated by SDS-PAGE  on 5-15 % polyacrylamide gradient gels, transferred to nitrocellu- 
lose, and subjected to immunoblotting. 
Neugebauer et al. A Conserved  Family of Splicing Factors  901 Figure 2. Localization of mAb 16H3 antigens to the nuclei of cultured L cells. (A) phase contrast image, (B) corresponding DAPI staining, 
and (C) indirect immunofluorescent  detection of mAb 16H3 followed  by a RITC-conjngated  secondary antibody. Note the intensity of mAb 
16H3 staining in the nucleus and the absence of staining in the phase-dark nucleoli. 
consistent with transcription (Sass,  1982). These data sug- 
gest that the 16H3 epitope is primarily nuclear and, further- 
more,  concentrated at  sites of active RNA polymerase II 
transcription. 
The localization of the 16H3 epitope to nuclei and active 
sites of transcription indicates that the high degree of com- 
plexity among 16H3 antigens might reflect a group of pre- 
mRNA  processing  proteins  larger  than,  but  overlapping 
with, the SR family of essential splicing factors. To deter- 
mine whether  161-13 antigens  interact with RNA  in  vivo, 
orthophosphate 32p-labeled  RNA  was  immunoprecipitated 
from HeLa cells under conditions that preserve interactions 
between proteins and RNA (Fig.  4).  Lane 2  shows the U 
snRNAs that coimmunoprecipitate with mAb Y12 antigens, 
integral components of most of the nonnucleolar U snRNPs 
(Petterson et al., 1984). mAb 16H3 immunoprecipitated the 
U1  snRNA very efficiently (lane 4) compared with a mAb 
against the U1 701( protein (lane 3; Billings et al., 1982) and 
mAb YI2. However, U2 snRNA was not detected in either 
anti-U1  701( o r  16H3 immunoprecipitates. The fact that 5S 
RNA, U3 snRNA, and tRNA were absent supports the ob- 
servation that 16H3 antigens are predominantly localized to 
the nucleoplasm and not the nucleolus or the cytoplasm. The 
observation that U1 snRNA immtmopurifies with a 16H3 an- 
tigen(s) indicates that mAb 16H3 does recognize other pre- 
raRNA  processing proteins, because immunoprecipitation 
of SR  proteins  alone yields  only high  molecular weight 
RNAs and none of the snRNAs (Roth et al.,  1991). 
Figure 3. Localization of mAb 16H3 antigens to active sites of tran- 
scription on Drosophila polytene chromosomes. (.4)  phase contrast 
image and (B) corresponding fluorescent image after treatment 
with mAb 16H3 and a RITC-conjngated secondary antibody. A de- 
velopmental puff is indicated in both panels by an arrowhead. 
lqgure 4. mAb 16H3 immuno- 
precipitates  32P-labeled  UI 
snRNA  from  HeLa  ceils. 
HeLa cells labeled for 4 h with 
[32p]Ol'thophosphate were  ex- 
tracted  and  incubated with 
beads coated with rnAb 3(12 
against the  Sm epitope (lane 
2), a mAb against U1 701( pro- 
tein (lane 3),  or mAb  161-I3 
(lane  4).  Extracted  RNAs 
were separated on a 10% poly- 
acrylamidc/7M urea gel, after 
which  the gel was dried down 
and  exposed  to  film. Total 
RNA  prepared  from  the  same 
extract  wcm run in lane 1. 
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16H3 antigens, we screened a X. /aev/s ovary expression li- 
brary with mAb 16H3.  Several of the cDNAs isolated were 
shown to encode the Xenopus U1  70K protein when their 
NH2 termini were sequenced, because the first 121  nucleo- 
tides predicted an amino acid sequence identical to amino 
acids  54-111  of the  published  sequence  (Etzerodt  et  al., 
1988).  The U1 70K protein is an integral component of the 
U1 snRNP and binds the U1 snRNA directly (Query et al., 
1989). This finding is consistent with the immunoprecipita- 
tion of U1  snRNA by mAb 16H3. 
Independent confirmation that mAb 16H3 binds U1 70K 
is shown in Fig. 5 A in which the U1 snRNP was immunopre- 
cipitated using the anti-U1 70K mAb (see above). The anti- 
gen-antibody complexes were subjected to SDS-PAGE and 
then reprobed by immunoblotting with either mAb 16H3 or 
the original anti-Ul 70K mAb. A control lane shows the anti- 
body bands (asterisks) present in the immune complexes and 
detected  by  the  immunoblotting  procedure.  As  expected, 
both the anti-U1  70K m_Ab and mAb 16H3 detect a  single 
band  at  the  appropriate  molecular  weight.  Neither  rnAb 
binds any of the other proteins present in the UlsnRNP; the 
core snRNP proteins B and B' were recognized in a parallel 
lane by mAb Y12 (data not shown). In a similar experiment 
(Fig. 5 B) designed to test mAb 16H3 reactivity with general 
U  snRNP proteins, snRNPs were immunoprecipitated with 
the mAb Y12, which binds three polypeptides known as B, 
B', and D  that are shared among the U  snRNPs (Pettersson 
et al.,  1984).  In the control lane, the antibody band is indi- 
cated with an asterisk. While a  doublet of reactive protein 
(28 and 29 kD) corresponding to B and B' was visible in the 
lane incubated with mAb Y12, these polypeptides were not 
detected by mAb 16H3.  However, mAb 16H3 did recognize 
the U1 70K protein in the same lane, indicating that intact 
U snRNPs had been immunoprecipitated. Therefore, the fact 
that other  U  snRNP polypeptides were not recognized by 
mAb 16H3 is further evidence of mAb 16H3's selectivity for 
particular RNA-binding proteins. 
To determine whether other classes of RNA-binding pro- 
teins are also 16H3 antigens, we tested mAb 16H3 reactivity 
with hnRNP proteins, which associate into large RNP com- 
plexes with pre-mRNA.  In Fig.  5  C,  intact hnRNP  com- 
plexes were immunoprecipitated from HeLa cell extracts by 
mAb 4F4 against one of '~ 20 hnRNP components, hnRNP 
C  (Choi and Dreyfuss,  1984; Dreyfuss et al.,  1993).  In the 
control lane, antibody bands are indicated by asterisks. The 
hnRNP C proteins were visualized by immunoblotting with 
mAb 4F4, and the hnRNP A proteins that coprecipitated are 
shown in the last lane, where they were bound by mAb 4B10 
(Choi and Dreyfuss, 1984). In the lane incubated with mAb 
16H3,  neither hnRNP proteins A  or C  were detected.  Fi- 
nally, mAb 16H3 did not bind recombinant, bacterially ex- 
pressed hnRNP U (Fig. 5 D), which was detected in a paral- 
lel lane by mAb 3G6.  Thus, m_Ab 16H3 has no affinity for 
the hnRNP proteins A,  C, or U. 
These results indicate that mAb 16H3 does not bind all 
pre-mRNA  processing  factors  in  general,  but  rather  has 
specificity for another set of nuclear proteins  localized to 
sites of RNA polymerase II transcription (summarized in Ta- 
ble I). Among these,  the SR proteins and U1  70K protein 
share two distinct structural motifs, the RRM and the SR do- 
main, a stretch of amino acids consisting almost entirely of 
Figure 5.  mAb  16H3 binds  U1  70K but not  core U  snRNP  or 
hnRNP  components.  (A)  U1  snRNPs  were  immunoprecipitated 
from a HeLa cell extract using an anti-U1 70K mAb (Billings et al., 
1982). Antibody-antigen  complexes were run on 10% SDS-PAGE 
and blotted to nitrocellulose.  Each lane was incubated with either 
20% FCS (control), the anti-U1 70K mAb, or mAb 16H3 as indi- 
cated below each lane. Bands detected independent of incubation 
with primary antibody during the blotting procedure are indicated 
with asterisks. These are antibody bands present because of  the im- 
munoprecipitation  procedure.  The U1 70K band is indicated.  (B) 
U  snRNPs  were  immanoprecipitated  from a  HeLa cell  extract 
using the anti-Sm mAb Y12 (Pettersson et al., 1984) and processed 
for immunoblotting  as described  in A.  Sm antigens B and B' de- 
tected in the Y12 blot are indicated.  Due to the small size of Sm 
antigen D, it would not have been resolved in this experiment. Only 
U1  70K,  which coprecipitalr,  xl with the core snRNP proteins,  is 
recognized by mAb 16H3. Both A and B were performed with anti- 
mouse IgG-conjugated magnetic  beads.  (C) hnRNP  complexes 
were  immunopurified  using  mAb 4F4  (bound  to  Gammabind) 
against the hnRNP A proteins  and examined by immunoblotting. 
hnRNPs C1 and C2 are detected by mAb 4F4 in the first lane, and 
hnRNP A1 and A2 by mAb 4B10 in the last. mAb 16H3 bound nei- 
ther of these doublets.  The 12.5% polyacrylamide  gels were run 
under nonreducing conditions so that most of the antibody mole- 
cules would migrate more slowly (i.e., in their unreduced form at 
approximately 180 kD). (D) In lanes 6and 7, 0.15 #g of bacterially 
expressed hnRNP U was run and subjected to immunoblotting by 
either  mAb 16H3 or mAb 3G6 against hnRNP  U. 
alternating arginine and serine (cf. Query et al.,  1989; Ke- 
nan et al.,  1991;  Zahler et al.,  1992).  mAb 16H3  reacted 
with bacterially expressed proteins containing intact U2AF  35 
and U2AF  65 as well as the arginine-rich domain of HRH1 
(Table  I;  data  not  shown).  HRH1  is  the  putative  human 
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Antigens  Not antigens 
SRp20  SRp30a 
SRp40  SRp30b 
SRp55  core snRNP proteins B and B' 
SRp75  hnRNP A1 and A2 
UI 70K  hnRNP C1 and C2 
U2AF  65  hnRNP U 
U2AF  35 
HRH1 
See Figs.  1 and 5 and text for details. 
homolog of the yeast Prp22, a member of the DEAH family 
of RNA helicases, which is involved in the release of spliced 
mRNA from the spliceosome. Although HRH1  and Prp22 
have extensive homology at the amino acid level, HRH1 ad- 
ditionally contains a 53-amino acid sequence of arginine al- 
ternating with serine and aspartate that is absent in Prp22 
(Company et  al.,  1991; One  et  al.,  1994).  U2AF  35  and 
U2AF  ~S are subunits of an essential 3' splice  site binding 
activity that  contain  SR  domains  (Zamore  et  al.,  1992; 
Zhang et al.,  1992).  Unlike all of the other 16H3 antigens 
identified thus far, U2AF  35 does not contain an RRM. To- 
gether with the demonstration that mAb 16H3 does not bind 
at least four proteins that contain RRMs (SRp30a and 30b, 
hnRNP proteins A and C; see Figs.  1 and 5), this suggests 
that mAb  16H3  does not have general specificity for the 
RRM class of RNA binding domains (Burd et al., 1989; Ke- 
nan et al., 1991; Zahler et al., 1992).  Instead, the profile of 
the known 16H3 antigens suggests that this set of proteins is 
specifically associated with pre-mRNA splicing rather than 
more general aspects of RNA metabolism. 
Because eight of the known 16H3 antigens are pre-mRNA 
splicing factors, we hypothesized that the unknown antigens, 
which do not occur in snRNP or hnRNP complexes, would 
be specifically concentrated in the multicomponent splicing 
complex, the spliceosome. To address this possibility, poly- 
peptide components of early (E)  and mature (B)  spliceo- 
somal complexes that had been assembled on biotinylated 
AdML pre-mRNA and isolated by gel filtration and affinity 
purification (Bennett et al., 1992a) were examined for reac- 
tivity with mAb 16H3. For comparison with the known set 
of antigens,  E  and B  complexes were separated by SDS- 
PAGE alongside HeLa nuclear extract.  Fig.  6  shows that 
mAb 16H3 specifically recognized many of the components 
of E  and B  complexes.  Compared with the polypeptides 
visualized by silver staining in Fig. 6 B (lane 1), mAb 16H3 
apw,  ars to react with approximately half of the detectable 
proteins purified in E complex (Fig. 6 A, lane 1 ). Consistent 
with mAb 16H3's reactivity with both subunits of U2AF (see 
above), two prominent 16H3-reactive bands in E  complex 
are certainly U2AF  s5 and U2AF% as judged by their abun- 
dance and migration in the gel (see Bennett et al.,  1992a). 
U1  70K is likely to comigrate with U2AF  65 at Mr 62,000. 
The other fainter bands of 200,  145, 125, 92,  and 65 kD 
comigrate with silver-stained bands in the parallel gel (Fig. 
6 B, lane 1 ). In B complex, major bands of 200,  160, 155, 
145, 135, 125, 105, 95, 82, 65, 57, 45, and 35 kD were de- 
tected in addition to the presumed U2AF and U1 70K bands 
(Fig. 6 A, lane 3). Comparison of the B complex blot with 
Figure 6. mAb 16H3 recognizes many polypeptide components of 
spliceosomes assembled in vitro. (A) mAb 16H3 immunoblot  of E 
complex (lane 1 ), nuclear extract (NE; lane 2), and B complex 
(lane 3) on a 7.5% polyacrylamide gel shows that '~20 reactive 
bands can be distinguished in nuclear extract. Of these, ,M0 can 
be detected in E and 11 in B complexes  at corresponding positions 
in the gel. (B) Silver stain of a parallel gel reveals the complexity 
of  polypeptides  in E complex (lane 1 ), nuclear extract (lane 2), and 
B complex 0ane 3). 
the silver-stained preparation suggests that more than half of 
the polypeptides present in B complex were reactive (Fig. 6 
B, lane 3). mAb 16H3 reactivity with E and B complex pro- 
teins appeared to be specific, because relatively abundant 
proteins detected by silver stain (e.g.,  a 50-kD band in B 
complex) were not reactive. It must also be noted, however, 
that the strict identification of bands cannot be made based 
on comigration in the blot and the silver stain. Finally, it was 
possible to align the majority of 16H3 reactive proteins de- 
tected in nuclear extract with those found in E and/or B com- 
plex: of the "o20 major bands in nuclear extract, 14 comi- 
grate with proteins that purify with these assembled splicing 
complexes. Because E and B complexes do not contain every 
component of the splicing machinery (e.g.,  SR proteins; 
Bennett et al., 1992a),  it is not surprising that several of the 
nuclear extract antigens are absent from E and B complexes. 
The  overwhelming conclusion of this  experiment  is  that 
16H3  antigens are  prominent  components of active  pre- 
mRNA splicing but not hnRNP or snRNP complexes. 
The evolutionary conservation of the 16H3 epitope and its 
concentrated presence in the spliceosome suggest that the 
epitope itself  may define a functional element on pre-mRNA 
splicing factors. To address this possibility, we assayed the 
effect of purified mAb 16H3 IgG on pre-mRNA splicing in 
vitro (Fig. 7). H/3A6 pre-mRNA substrate is efficiently con- 
vetted  to  product  in  a  reaction  containing  a  splicing- 
competent HeLa nuclear extract.  In lanes 1-3,  increasing 
amounts of 16H3  IgG (0.25-1.25  #g) were added and re- 
suited in a decrease in both the amount of spliced product 
as well as intermediates. These data can be compared to the 
control reactions (lanes 4-6), which took place in the pres- 
ence of equal quantities of nonimmune mouse IgG. Another 
control performed with a monoclonal IgG to a frog nuclear 
antigen yielded similar results to the control shown here 
(data not shown). The fact that splicing intermediates do not 
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hibits pre-mRNA splicing in 
vitro. 32p-labeled HBA6 pre- 
mRNA was incubated for 2 h 
at 30°C under splicing condi- 
tions in HeLa cell nuclear ex- 
tract in the presence of either 
purified 16H3 IgG (0.25, 0.63, 
and 1.25 #g in lanes 1, 2, and 
3, respectively)  or nonimmune 
mouse IgG  (0.25, 0.63, and 
1.25 #g in lanes 4,  5,  and  6, 
respectively).  The  resulting 
RNAs were subjected  to dena- 
turing electrophoresis in 5 % 
acrylamide gels, dried down, 
and  exposed to  film. Pre- 
mRNA,  intermediates, and 
product are indicated. 
accumulate suggests that mAb 16H3 inhibits splicing before 
the first transesterification reaction. 
The fact that mAb 16H3 inhibits in vitro splicing suggests 
that the epitope itself may participate in spliceosome assem- 
bly. It is therefore of  interest to define the 16H3 epitope more 
precisely. A partial eDNA was isolated and sequenced from 
the mAb 16H3  screen of the Xenopus ovary expression li- 
brary, and we used this clone to map the 16H3 epitope. This 
eDNA was chosen for the analysis because, unlike many of 
the other 16H3 antigens, it was expressed at high levels by 
bacterial cells. The sequence of the  1,441-nucleotide-long 
clone did not reveal  any identities or  strong  similarities 
within the data base. A weak similarity to the RRM of yeast 
poly-A polymerase was observed,  suggesting that the en- 
coded protein may bind RNA. The most remarkable feature 
of the predicted amino acid sequence was the presence of a 
region consisting almost entirely of arginine alternating with 
glutamate or occasionally aspartate (Fig. 8 A). A fusion of 
this sequence with (;ST was created, and the expressed pro- 
tein was shown to react with mAb 16H3 by immunoblot (Fig. 
8 B, lane 1 ). It is striking that each of the seven known 16H3 
antigens contains a domain characterized by arginine alter- 
nating  with  serine,  glutamate,  and  aspartate  in  varying 
proportions (Etzerodt et al., 1988; Query et al., 1989; Zah- 
ler et al.,  1992;  Zamore et al.,  1992;  Zhang et al.,  1992; 
Ono et al., 1994).  Thus, it is possible that mAb 16H3 binds 
each antigen in its arginine-rich domain. 
Discussion 
We  have  developed  a  monoclonal antibody  (16H3)  with 
Figure 8. The 16H3 epitope is contained in a sequence of alternat- 
ing glutamate and arginine. (A) deduced 40-amino acid sequence 
of the protein fragment that was fused to GST. (B) mAb 16H3 
recognizes the GST fusion protein containing the alternating argi- 
nine domain shown in A by immunoblot (lane I), but does not 
recognize expressed GST alone (lane 2). 
specificity for a subset of the SR protein family of essential 
pre-mRNA splicing factors. In addition to SRp75, SRp55, 
SRp40, and SRp20, this mAb recognizes ,,020 prominent nu- 
clear proteins, which can be accounted for, at least in part, 
by protein components of biochemically defined pre-mRNA 
splicing complexes, These include the UI 70K component of 
the U1 snRNP and both subunits of U2AF, a factor that binds 
to the 3' splice site. In contrast, mAb 16H3 antigens do not 
appear to occur in snRNP or hnRNP complexes (see Table 
I for summary). Although mAb 16H3 binds this collection 
of proteins in humans, Drosophila, and frog, reactive pro- 
teins are not detectable in yeast cells,  suggesting that the 
16H3 epitope is conserved among pre-mRNA splicing fac- 
tors but limited to metazoans. We therefore consider the pos- 
sibility that the 16H3 epitope itself defines a functional ele- 
ment uniquely required in metazoan pre-mRNA processing. 
Initially, mAb  16H3  was shown to bind SRp75, SRp55, 
SRp40,  and SRp20,  but not SRp30a  or SRp30b.  Surpris- 
ingly, immunoblotting experiments indicate that a minimum 
of 20 major 16H3-reactive bands are present in HeLa cells 
and nuclear extract, amphibian nuclei, and Drosophila nu- 
clear extract. Two of the reactive polypeptides in HeLa cells 
(190 and 125 kD) appear to comigrate with two mAb 104- 
reactive bands, raising the intriguing possibility that these 
two 16H3  antigens are members of the SR protein family 
(Roth et al., 1989; Zahler et al.,  1993b).  However,  SR pro- 
reins are defined not only as mAh 104 antigens, but by three 
other  criteria:  their  quantitative  recovery  in  a  two-step 
purification  scheme,  their  ability to  complement  a  pre- 
rnRNA splicing-deficient S100 extract in vitro, and two fea- 
tures of their primary structure, an RRM that is conserved 
within the family and an SR domain consisting almost en- 
tirely of  alternating serine and arginine (Zahler et al., 1992). 
Because these additional criteria have not yet been satisfied 
for the two high molecular weight 16H3/104  antigens, they 
cannot yet be named SR proteins. Certainly, the presence of 
numerous mAb  104-reactive polypeptides in the Xenopus 
germinal vesicle indicate that additional SR proteins may 
well exist (Roth et al.,  1989). 
Consistent with the notion that 16H3 antigens represent a 
set of factors involved in the processing of RNA polymerase 
II transcripts are the observations that mAb 16H3 immuno- 
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curs at active sites of transcription. The nuclear staining ob- 
served in mouse tissue culture cells has a grainy quality but 
is not confined to "speckles" or coiled bodies that have been 
observed  by  others  using  antibodies  with  more  limited 
specificity (of.  Nyman et al.,  1986;  Moore et al.,  1993). 
Rather, the level of staining throughout the nucleus seems to 
reflect the punctate staining obtained with mAbs against SR 
proteins (e.g., mAb 104 or SC-35) in addition to an evenly 
distributed pool of protein. At least some fraction of anti- 
genie proteins can become concentrated at the sites of active 
RNA polymerase II transcription, such as the intensely mAb 
16H3-reactive developmental puffs observed on polytene 
chromosomes (see Fig. 2). This pool of proteins, while di- 
verse in apparent molecular weight, is quite limited in the 
types of RNAs with which it interacts. For example, mAb 
16H3 does not immunoprecipitate tRNA or the nucleolar 
RNAs, U3 snRNA or 5S. However,  the U1 snRNA is spe- 
cifically immunoprecipitated, most likely reflecting the in- 
teraction between mAb 161-13 and the U1 70K protein, which 
is an integral component of the U1 snRNP and can bind U1 
snRNA directly (Query et al., 1989;  for review see Moore 
et al., 1993). Interestingly, the U2 snRNA was not immuno- 
precipitated,  consistent with the demonstration that mAb 
16H3  does  not  recognize  the  common  components  of 
snRNPs, like the Sm antigens (Pettersson et al.,  1984). 
The fact that pre-mRNA splicing factors are among the 
16H3 antigens localized to active sites of transcription fo- 
cused our attention on RNP complexes known to occur on 
nascent RNA transcripts.  As transcription proceeds,  pre- 
RNAs become coated with heterogeneous complexes called 
hnRNPs that contain at least 20 major proteins (cf. Dreyfuss 
et  al.,  1993).  In  addition,  some  pre-mRNA  processing 
events, such as the removal of introns, can occur cotranscrip- 
tionally (Beyer et al., 1981). Indeed, SR proteins are local- 
ized to active transcription units on Xenopus  lampbrush and 
Drosophila  polytene chromosomes (Roth et al., 1989, 1991). 
To determine whether mAb 16H3 recognizes components of 
either of these RNPs, we probed immunopurified hnRNPs 
and spliceosomes assembled in vitro, mAb  16H3  did not 
recognize recombinant hnRNP U or hnRNP proteins A and 
C that were immunopurified in hnRNP complexes. In con- 
trast, mAb  16H3 did react with many of the polypeptides 
present in the spliceosomal complexes E and B, suggesting 
that the expression of the 16H3 epitope in RNPs is limited 
to active splicing RNPs rather than more ubiquitous RNPs 
that also function in assembly and transport (e.g., snRNPs 
and hnRNPs; cf. Mattaj,  1988;  Dreyfuss et al,,  1993). 
The protein components of  purified complexes E and B are 
specifically associated with the spliceosome, because they 
do not accumulate on RNAs lacking functional 5' and 3' 
splice sites (Bennett et al., 1992a),  E complex describes the 
collection of nuclear proteins that assembles at a splice junc- 
tion in the absence of ATP and is considered, therefore, a 
prespliceosome (Michaud and Reed, 1991). Upon the addi- 
tion of ATE this complex can be chased into B complex, 
which contains additional proteins  assembled during the 
splicing reaction. E  complex contains U1  snRNP proteins 
and U2AF  in  addition to  seven major spliceosome-asso- 
ciated proteins, while B complex contains U2 and U5 snRNP 
proteins and 20 spliceosome-associated proteins (Bennett et 
al.,  1992a;  Michaud and Reed,  1993).  mAb 16H3  recog- 
nizes U1 70K, U2AF% and U2AF  35 in both E and B com- 
plexes,  confirming the independent demonstration that all 
three recombinant proteins bind the mAb. In addition, mAb 
16H3 binds five less abundant proteins in E complex, some 
of which are further enriched in B complex. B complex con- 
tains an additional nine mAb  16H3-reactive polypeptides 
that are not detectable in E complex. Nonreactive proteins 
are also present in E  and B complex, consistent with our 
knowledge that mAb 16H3 does not bind the core saRNP 
components (e.g., Sm antigens B and Bg, which are present 
in  both  E  and  B  complexes  (Bennett  et  al.,  1992a). 
Significantly,  most of the reactive bands in nuclear extract 
(,x,70%) can be aligned with reactive bands in E and/or B 
complex.  It is  not yet known whether the  16H3  antigen 
HRHI is present in either complex, but a number of  antigens, 
particularly in B complex, approximate the predicted molec- 
ular mass of HRH1 (150 kD; Ono et al., 1994).  Naturally, 
failure to detect a given band in any of the lanes might reflect 
the relative abundance of the polypeptide rather than its ab- 
solute presence or absence. Moreover, a number of splicing 
factors, notably the SR proteins, do not copurify with E or 
B complex (Bennett et al., 1992a).  C complex, which con- 
tains the largest number of spliceosome-associated proteins, 
was not tested and may contain additional 16H3  antigens 
(Gozani et al., 1994). The conclusion that 16H3 antigens are 
components of the pre-mRNA splicing pathway is supported 
by the  observations  that mAb  16H3  inhibits pre-mRNA 
splicing in vitro and can immunodeplete nuclear extract of 
splicing activity (data not shown), mAb 16I-I3 will be an im- 
portant reagent in identifying and cloning cDNAs encoding 
metazoan splicing factors, as it has already been useful in 
expression-screening experiments. 
These results indicate that the 16H3 epitope is present, to 
the best of our knowledge, exclusively on pre-mRNA splic- 
ing factors. This correlation and the fact that mAb 161-I3 in- 
hibits in vitro splicing suggest that the 16H3 epitope itself 
may be a functional element on this set of proteins. Thus, it 
is of interest to determine the minimally required amino acid 
sequence capable of binding mAb  16H3.  To that end, we 
mapped the epitope to a 40-amino acid-long stretch of argi- 
nine alternating primarily with glutamate and sometimes 
aspartate (see Fig. 8 A). This sequence was derived from a 
partial eDNA isolated in a bacterial expression screen. The 
cDNA contains a region of weak similarity to yeast poly- 
A-binding protein, but otherwise contains no other known 
homologies. Strikingly, all of  the other known 16H3 antigens 
also contain regions  of alternating  arginine.  The arginine- 
rich domains of SRp75, SRp55, SRp40, SRp20, and the 
U2AF proteins  contain arginine  alternating  with predomi- 
nantly serine  rather  than glutamate or aspartatc,  although 
these  amino acids  are  also  present  (Zahler  et  al.,  1992; Za- 
more ct al.,  1992; Zhang et al.,  1992). The analogous do- 
mains in UI 701( and HRHI  contain  arginine  alternating 
with all  three  amino acids-serine,  glutamate,  and aspartate 
(Etzcrodt  et  al.,  1988; Query et  al,,  1989; Ono et  al.,  1994). 
The fact  that  neither  SRp30a nor  SRp30b reacts  suggests  that 
glutamate  provides  a  key component of  the  epitope,  because 
neither  of  these  SR proteins  contains  any  glutamate-arginine 
(ER) combinations (Fu and  Maniatis,  1992; Ge et  al.,  1991; 
Krainer ct al.,  1991).  Similarly,  nonreactive  proteins-the 
core snRNP proteins  B and B', and hnRNP proteins  A, C, 
and U-contain few,  if  any,  ER (Burd  ct  al.,  1989; van Dam 
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to note that  while hnRNP  U  is rich  in both arginine  and 
glutamate and contains an RGG repeat domain,  it contains 
no ER and does not react with m_Ab 16H3 (Kiledjian and 
Dreyfuss,  1992). 
Because 16H3 antigens were not detected in yeast, we sug- 
gest that 16H3 antigens and possibly the epitope itself per- 
form a regulatory function(s) uniquely required in metazoan 
pre-mRNA processing. The fact that m_Ab 16H3 inhibits in 
vitro splicing reactions in HeLa call nuclear extracts  sup- 
ports this view. Repeated efforts to detect 16H3 antigens in 
extracts of S.  cerevisiae and S. pombe and in a S.  cerevisiae 
expression library have failed. Indeed, independent attempts 
to detect SR proteins in yeast with the anti-SR protein mAb 
104 or by biochemical purification have also been fruitless 
(Zahler, A. M., and M. B. Roth, unpublished observations). 
Splice site definition in yeast, in contrast to higher eukary- 
otes, is predominantly  constitutive and governed by highly 
conserved cis sequences at the 5' and 3' splice sites and by 
the yeast-specific UACUAAC box at the branch point (Guth- 
tie, 1991), suggesting the need for additional protein-protein 
or protein-RNA interactions in the metazoan spliceosome. 
Interestingly,  the putative yeast homolog of U1  70K com- 
pletely  lacks  the  arginine-rich  domain  characteristic  of 
metazoan U1 70K proteins,  while other structural features 
have been conserved (Smith and Barrell,  1991).  Similarly, 
the human homolog of yeast Prp22, a member of the DEAH 
family of ATP-dependent RNA helicases, contains an SR do- 
main that is not present in the yeast protein (Company et al., 
1991;  Ono et al.,  1994),  suggesting that further metazoan 
homologs of yeast splicing factors will encode added func- 
tional domains. 
We speculate that this domain of arginine alternating with 
serine,  glutamate,  and/or aspartate is a structural  motif of 
protein pre-mRNA splicing factors, of which the SR domain 
is a subtype. Recent studies indicate that SR domains and the 
SR-like domains of U1 70K and U2AF are required for splic- 
ing and may mediate both protein-protein and protein-RNA 
interactions  in the spliceosome (Zamore et al.,  1992;  Ca- 
ceres and Krainer, 1993; Khotz et al., 1994; Wu and Mania- 
tis,  1993; Amrein et al.,  1994; Ono et al.,  1994). Because 
arginine is a basic amino acid, glutamate and aspartate are 
acidic, and serine is highly phosphorylated on SR proteins 
(Roth et al., 1989; Zahler et al.,  1993b), it seems likely that 
the general structure of the domain would be determined by 
the pattern of alternating positive and negative charges.  In- 
deed, theoretical considerations (Perutz,  1994) suggest that 
this pattern exemplified in the U1 70K protein might adopt 
a  "polar zipper"  conformation,  consisting  primarily  of an 
antiparallel  B-barrel  in which all of the charges  are com- 
pensated. It is intriguing to consider that the unknown 16H3 
antigens also contain such highly charged arginine-rich do- 
mains, and that the metazoan spliceosome may contain many 
of these unusual  structures. 
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